- - -
we are hiring

Jobs and opportunities

Consultancy to develop a Statement on Preventing Female Genital Mutilation

Consultancy to develop a Statement on Preventing Female Genital Mutilation for the IPPF’s International Medical Advisory Panel (IMAP)

Deadline

Purpose

FGM as a form of Gender Based Violence (GBV) remains persistent across contexts, including in high-income countries, due to the impact of migration, displacement and changes in norms around sexuality. A new IMAP statement on FGM will assess emerging trends in FGM prevalence, map the existing evidence on successful FGM prevention interventions as well as survivor-centred service delivery models. The statement will also provide evidence-informed recommendations on constructive surgical interventions that can be integrated in SRH and GBV services provided by IPPF Member Associations in FGM prevalent countries and highlight current research gaps.  This statement will also serve as a tool for advocacy to mobilise actors to denounce all forms of FGM and to assert commitment to reduce and eradiate its medicalisation as a violation of human rights and to the providers’ code of conduct. 

 

The Statement

Length: Ideally six pages – maximum eight pages.

Number of working days: 8-10 working days

Target audience: Primarily IPPF Member Associations. Also, other SRH and GBV organizations, donors, ministries of health and the broader development community, including WHO and other UN agencies.  IMAP Statements have a global reach.

Tone: Evidence-based and technical but accessible, with references to further information for those who want more technical detail or link to guidelines and other resources.  Please review previous IMAP statements via IPPF’s website and use a similar tone/language.

Purpose: Guide IPPF Member Associations and other SRHR organizations to develop, strengthen, and sustain interventions (prevention, survivor-centred response, surgical treatment if needed and advocacy) on FGM services in development and humanitarian settings.

References: The statement should have relevant and up to date references cited. 

Acknowledgement: The author will be acknowledged (unless requested not to be).  IMAP members and other key reviewers of the statement are acknowledged in the statement. 

 

Application

Interested consultants are advised to send their CV, daily rate and list of your relevant publications/written work on FGM/GBV to Ms. Siwar Madkouri at email: [email protected] by 25 August 2025 COB